NCT05556356

Brief Summary

Basilar thumb arthritis is a common problem that affects 7% of men and 15% of women. It is regarded as one of the more painful procedures commonly performed by hand surgeons. Opioid overuse and diversion are significant problems in the country that contribute to opioid addiction as well as deaths from opioid overdose. Prior studies have examined the effect of different nerve block compositions on perioperative and postoperative analgesia, but none have looked at perioperative loading analgesia. We will attempt to address this problem by exploring alternative analgesia regimens to decrease opioid prescribing after 1st carpometacarpal (CMC) joint arthroplasty.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 13, 2022

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

September 22, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 27, 2022

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 6, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 6, 2024

Completed
Last Updated

October 8, 2024

Status Verified

October 1, 2024

Enrollment Period

1.6 years

First QC Date

September 22, 2022

Last Update Submit

October 1, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Visual Analogue Scale (VAS)

    Patients report pain on a scale of 0 (no pain) to 100 (worst possible pain)

    2 weeks

  • Number of Narcotic Pills Used

    Number of Narcotic Pills Used

    2 weeks

Study Arms (2)

Control Group

PLACEBO COMPARATOR

Preoperative multivitamin and postoperative standardized pain management regimen

Other: Placebo: Multivitamin

Test Group

EXPERIMENTAL

: Preoperative acetaminophen and postoperative standardized pain management regimen

Drug: Acetaminophen

Interventions

pre-operative acetaminophen (1000mg)

Also known as: Tylenol
Test Group

pre-operative Multivitamin

Control Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults (18 years of age or older)
  • Patients presenting with symptomatic 1st CMC arthritis with or without scaphotrapeziotrapezoid arthritis
  • Eaton Classification stage II, III, or IV OA of the first CMC joint based on xrays
  • Patients who plan to undergo a ligament reconstruction and tendon interposition (LRTI) or thumb suspensionplasty procedure within 6 months of enrolling to study
  • Bilateral thumbs included

You may not qualify if:

  • \<18 years age
  • Prior surgical history of ipsilateral 1st CMC arthroplasty or procedures involving thumb CMC joints
  • Prior ipsilateral tendon rupture or ipsilateral peripheral nerve palsy
  • History of opioid dependency or current chronic opioid use
  • Contraindication to acetaminophen use
  • Contraindication to NSAID use
  • Contraindication or known allergy to peripheral nerve blockade, including coagulopathy
  • Contraindication to supraclavicular block due to anatomic variability or inability to tolerate phrenic nerve blockade.
  • Contraindication to multivitamin use
  • Liver dysfunction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Indiana Hand to Shoulder Center

Indianapolis, Indiana, 46260, United States

Location

MeSH Terms

Interventions

Acetaminophen

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
Participants unblinded following final data collection.
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 22, 2022

First Posted

September 27, 2022

Study Start

September 13, 2022

Primary Completion

May 6, 2024

Study Completion

May 6, 2024

Last Updated

October 8, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations